We are live on
!
Find out more
GAM
Generali Asset Management Portfolio holdings
AUM
$4.79B
1-Year Est. Return
26.21%
This Fund
S&P 500
This Quarter
Est. Return
-2.83%
1 Year Est. Return
+26.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.79B
AUM Growth
-$98.5M
(-2%)
Cap. Flow
+$223M
Cap. Flow
% of AUM
4.65%
Top 10 Holdings %
Top 10 Hldgs %
32.74%
Holding
513
New
30
Increased
185
Reduced
226
Closed
29
Top Buys
| 1 |
AstraZeneca
AZN
|
+$184M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$101M |
| 3 |
Ares Capital
ARCC
|
+$48.3M |
| 4 |
Cameco
CCJ
|
+$16.4M |
| 5 |
Blackstone Secured Lending
BXSL
|
+$11.8M |
Top Sells
| 1 |
Newmont
NEM
|
+$28.3M |
| 2 |
Wheaton Precious Metals
WPM
|
+$18.8M |
| 3 |
Agnico Eagle Mines
AEM
|
+$17.9M |
| 4 |
NVIDIA
NVDA
|
+$8.21M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$7.43M |
Sector Composition
| 1 | Technology | 26.46% |
| 2 | Financials | 21.2% |
| 3 | Healthcare | 9.95% |
| 4 | Communication Services | 9.25% |
| 5 | Consumer Discretionary | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Moderna
MRNA
$24.5B
| – | – |
-56,799
| Closed | -$1.68M |
|
502
MSCI
MSCI
$45.8B
| – | – |
-2,697
| Closed | -$1.55M |
|
503
M&T Bank
MTB
$36.1B
| – | – |
-11,513
| Closed | -$2.32M |
|
504
Nutanix
NTNX
$14.9B
| – | – |
-34,820
| Closed | -$1.8M |
|
505
PTC
PTC
$14.4B
| – | – |
-9,653
| Closed | -$1.68M |
|
|
SMLR
506
DELISTED
Semler Scientific
SMLR
| – | – |
-100,000
| Closed | -$1.53M |
|
507
Twilio
TWLO
$31.4B
| – | – |
-12,838
| Closed | -$1.83M |
|
508
United Airlines
UAL
$37.5B
| – | – |
-11,682
| Closed | -$1.31M |
|
509
W.R. Berkley
WRB
$26.7B
| – | – |
-23,245
| Closed | -$1.63M |
|
510
Zoom
ZM
$26.7B
| – | – |
-19,735
| Closed | -$1.7M |
|
511
Zscaler
ZS
$24.2B
| – | – |
-6,865
| Closed | -$1.54M |
|
|
MRP
512
Millrose Properties Inc
MRP
$4.89B
| – | – |
-63
| Closed | -$1.88K |
|
|
SOLS
513
Solstice Advanced Materials
SOLS
$9.27B
| – | – |
-4,057
| Closed | -$197K |
|
Similar funds
CA
PTC
JSTA
MP
WAM
MF
TPCW
IA
Generali Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Generali Asset Management held 513 positions worth $4.79B, down 2% from $4.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Generali Asset Management deployed $223M of net new capital in Q1 2026, opening 30 new positions and adding to 185 existing holdings. Its largest new stake was AstraZeneca: 954,783 shares worth $140M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Newmont, an estimated $28.3M trimmed.
- Generali Asset Management's largest Q1 2026 buy was AstraZeneca: 954,783 shares worth $140M.
- Generali Asset Management added most to Ares Capital in Q1 2026, an estimated $48.3M increase.
- Generali Asset Management's biggest Q1 2026 reduction was Newmont, cutting an estimated $28.3M.
- Generali Asset Management fully exited M&T Bank in Q1 2026, selling an estimated $2.32M.
- Generali Asset Management's ten largest holdings make up 33% of its $4.79B portfolio in Q1 2026.
- Generali Asset Management opened 30 new positions and closed 29 in Q1 2026.
- Generali Asset Management's portfolio value fell 2% quarter-over-quarter to $4.79B.
Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.